Adaptive myogenesis under hypoxia

Molecular and Cellular Biology

Volumn 25, Issue 8, 2005, Pages 3040-3055

  Yun, Zhong ^a   Lin, Qun ^a   Giaccia, Amato J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HISTONE; HYPOXIA INDUCIBLE FACTOR 1; MYOD PROTEIN; MYOGENIN; OXYGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEACETYLATION; EVOLUTIONARY ADAPTATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOXIA; MICROENVIRONMENT; MOUSE; MUSCLE DEVELOPMENT; MUSCLE ISCHEMIA; MYOBLAST; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; UBIQUITINATION;

ACETYLATION; ADAPTATION, PHYSIOLOGICAL; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE; HISTONES; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUSCLE DEVELOPMENT; MYOBLASTS; MYOCYTES, CARDIAC; MYOD PROTEIN; MYOGENIN; NUCLEAR PROTEINS; OXYGEN; PROMOTER REGIONS (GENETICS); RNA STABILITY; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 16244406228     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.8.3040-3055.2005     Document Type: Article

References (55)

1. Arthur, P. G., J. J. Giles, and C. M. Wakeford. 2000. Protein synthesis during oxygen conformance and severe hypoxia in the mouse muscle cell line C2C12. Biochim. Biophys. Acta 1475:83-89.
2. Azmi, S., H. Sun, A. Ozog, and R. Taneja. 2003. mSharp-1/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expression. J. Biol. Chem. 278:20098-20109.
3. Baker, B. W., D. Boettiger, E. Spooncer, and J. D. Norton. 1992. Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor. Nucleic Acids Res. 20:5234.
4. Becker, A., P. Stadler, R. S. Lavey, G. Hansgen, T. Kuhnt, C. Lautenschlager, H. J. Feldmann, M. Molls, and J. Dunst. 2000. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 46:459-466.
5. Bigard, A. X., H. Sanchez, O. Birot, and B. Serrurier. 2000. Myosin heavy chain composition of skeletal muscles in young rats growing under hypobaric hypoxia conditions. J. Appl. Physiol. 88:479-486.
6. Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
7. Boudjelal, M., R. Taneja, S. Matsubara, P. Bouiliet, P. Dolle, and P. Chambon. 1997. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 11:2052-2065.
8. Brevetti, L. S., D. S. Chang, G. L. Tang, R. Sarkar, and L. M. Messina. 2003. Overexpression of endothelial nitric oxide synthase increases skeletal muscle blood flow and oxygenation in severe rat hind limb ischemia. J. Vasc. Surg. 38:820-826.
9. Bruick, R. K. 2003. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 17:2614-2623.
10. Caro, J. 2001. Hypoxia regulation of gene transcription. High Alt. Med. Biol. 2:145-154.
11. Chan, D. A., P. D. Sutphin, N. C. Denko, and A. J. Giaccia. 2002. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem. 277:40112-40117.
12. Charge, S. B., and M. A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84:209-238.
13. Chen, J. C., and D. J. Goldhamer. 2004. The core enhancer is essential for proper timing of MyoD activation in limb buds and branchial arches. Dev. Biol. 265:502-512.
14. Chen, J. C., and D. J. Goldhamer. 1999. Transcriptional mechanisms regulating MyoD expression in the mouse. Cell Tissue Res. 296:213-219.
15. Chen, J. C., C. M. Love, and D. J. Goldhamer. 2001. Two upstream enhancers collaborate to regulate the spatial patterning and timing of MyoD transcription during mouse development. Dev. Dyn. 221:274-288.
16. Chin, M. T., K. Maemura, S. Fukumoto, M. K. Jain, M. D. Layne, M. Watanabe, C. M. Hsieh, and M. E. Lee. 2000. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J. Biol. Chem. 275:6381-6387.
17. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, G. S. Firestein, H. P. Gerber, N. Ferrara, and R. S. Johnson. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645-657.
18. Di Carlo, A., R. De Mori, F. Martelli, G. Pompilio, M. C. Capogrossi, and A. Germani. 2004. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J. Biol. Chem. 279:16332-16338.
19. Elson, D. A., H. E. Ryan, J. W. Snow, R. Johnson, and J. M. Arbeit. 2000. Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 60:6189-6195.
20. Elson, D. A., G. Thurston, L. E. Huang, D. G. Ginzinger, D. M. McDonald, R. S. Johnson, and J. M. Arbeit. 2001. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev. 15:2520-2532.
21. Genbacev, O., Y. Zhou, J. W. Ludlow, and S. J. Fisher. 1997. Regulation of human placental development by oxygen tension. Science 277:1669-1672.
22. Giaccia, A. J., M. C. Simon, and R. Johnson. 2004. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev. 18:2183-2194.
23. Hawke, T. J., and D. J. Garry. 2001. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91:534-551.
24. Hoppeler, H., E. Kleinert, C. Schlegel, H. Claassen, H. Howald, S. R. Kayar, and P. Cerretelli. 1990. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J. Sports Med. 11(Suppl. 1):S3-S9.
25. Howald, H., and H. Hoppeler. 2003. Performing at extreme altitude: muscle cellular and subcellular adaptations. Eur. J. Appl. Physiol. 90:360-364.
26. Hunter, J. G., M. F. van Delft, R. A. Rachubinski, and J. P. Capone. 2001. Peroxisome proliferator-activated receptor γ ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor γ-dependent and -independent pathways. J. Biol. Chem. 276:38297-38306.
27. Iso, T., L. Kedes, and Y. Hamamori. 2003. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol. 194:237-255.
28. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12:149-162.
29. Kayser, B., H. Hoppeler, H. Claassen, and P. Cerretelli. 1991. Muscle structure and performance capacity of Himalayan Sherpas. J. Appl. Physiol. 70:1938-1942.
30. Laderoute, K. R., J. M. Calaoagan, M. Knapp, and R. S. Johnson. 2004. Glucose utilization is essential for hypoxia-inducible factor 1α-dependent phosphorylation of c-Jun. Mol. Cell. Biol. 24:4128-4137.
31. Leary, S. C., B. C. Hill, C. N. Lyons, C. G. Carlson, D. Michaud, C. S. Kraft, K. Ko, D. M. Glerum, and C. D. Moyes. 2002. Chronic treatment with azide in situ leads to an irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation. J. Biol. Chem. 277:11321-11328.
32. Lee, S. H., P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite. 2000. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:626-633.
33. MacDougall, J. D., H. J. Green, J. R. Sutton, G. Coates, A. Cymerman, P. Young, and C. S. Houston. 1991. Operation Everest II: structural adaptation in skeletal muscle in response to extreme simulated altitude. Acta Physiol. Scand. 142:421-427.
34. Mason, S. D., R. A. Hewlett, M. J. Kim, I. M. Olfert, M. C. Hogan, W. McNulty, R. P. Hickey, P. D. Wagner, C. R. Kahn, F. J. Giordano, and R. S. Johnson. 24 August 2004, posting date. Loss of skeletal muscle HIF-1α results in altered exercise endurance. PLoS Biol. 2:e288. [Online.] doi: 10.1371/journal.pbio.0020288.
35. Nofziger, D., A. Miyamoto, K. M. Lyons, and G. Weinmaster. 1999. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126:1689-1702.
36. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
37. Pfander, D., T. Kobayashi, M. C. Knight, E. Zelzer, D. A. Chan, B. R. Olsen, A. J. Giaccia, R. S. Johnson, V. H. Haase, and E. Schipani. 2004. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131:2497-2508.
38. Puri, P. L., and V. Sartorelli. 2000. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell. Physiol. 185:155-173.
39. Rando, T. A., and H. M. Blau. 1994, Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275-1287.
40. Rissanen, T. T., I. Vajanto, M. O. Hiltunen, J. Rutanen, M. I. Kettunen, M. Niemi, P. Leppanen, M. P. Turunen, J. E. Markkanen, K. Arve, E. Alhava, R. A. Kauppinen, and S. Yla-Herttuala. 2002. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 160:1393-1403.
41. Sabourin, L. A., and M. A. Rudnicki. 2000. The molecular regulation of myogenesis. Clin. Genet. 57:16-25.
42. Safran, M., and W. G. Kaelin, Jr. 2003. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111:779-783.
43. Sastre, M., H. Steiner, K. Fuchs, A. Capell, G. Multhaup, M. M. Condron, D. B. Teplow, and C. Haass. 2001. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2:835-841.
44. Scheidegger, K. J., M. H. Nelissen-Vrancken, P. J. Leenders, M. J. Daemen, J. F. Smits, and J. M. Wood. 1997. Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system. J. Hypertens. 15:1455-1462.
45. Schipani, E., H. E. Ryan, S. Didrickson, T. Kobayashi, M. Knight, and R. S. Johnson. 2001. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 15:2865-2876.
46. Scholz, D., S. Thomas, S. Sass, and T. Podzuweit. 2003. Angiogenesis and myogenesis as two facets of inflammatory post-ischemic tissue regeneration. Mol. Cell. Biochem. 246:57-67.
47. Seale, P., A. Asakura, and M. A. Rudnicki. 2001. The potential of muscle stem cells. Dev. Cell 1:333-342.
48. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:721-732.
49. Shen, M., T. Kawamoto, W. Yan, K. Nakamasu, M. Tamagami, Y. Koyano, M. Noshiro, and Y. Kato. 1997. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem. Biophys. Res. Commun. 236:294-298.
50. Springer, M. L., T. A. Rando, and H. M. Blau. 2003. Gene delivery to muscle, p. 13.4. In N. C. Dracopoli, J. L. Haines, B. R. Korf, C. C. Morton, C. E. Seidman, J. G. Seidman, and D. R. Smith (ed.), Current protocols in human genetics. John Wiley & Sons, New York, N.Y.
51. Studer, L., M. Csete, S. H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay. 2000. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20:7377-7383.
52. Sun, J., C. N. Kamei, M. D. Layne, M. K. Jain, J. K. Liao, M. E. Lee, and M. T. Chin. 2001. Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J. Biol. Chem. 276:18591-18596.
53. Wei, Q., and B. M. Paterson. 2001. Regulation of MyoD function in the dividing myoblast. FEBS Lett. 490:171-178.
54. Yun, Z., and A. J. Giaccia. 2003. Tumor deprivation of oxygen and tumor suppressor gene function. Methods Mol. Biol. 223:485-504.
55. Yun, Z., H. L. Maecker, R. S. Johnson, and A. J. Giaccia. 2002. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2:331-341.